129 related articles for article (PubMed ID: 6117168)
1. hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids.
Oberg K; Wide L
Acta Endocrinol (Copenh); 1981 Oct; 98(2):256-60. PubMed ID: 6117168
[TBL] [Abstract][Full Text] [Related]
2. HCG-alpha and HCG-beta subunits as tumour markers during therapy in a case with so-called "non-functioning" islet cell tumour.
Oberg K; Wide L; Boström H
Acta Med Scand; 1981; 210(3):231-3. PubMed ID: 6270988
[TBL] [Abstract][Full Text] [Related]
3. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
[TBL] [Abstract][Full Text] [Related]
4. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
5. Alpha-subunit and human chorionic gonadotropin-beta immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumours.
Grossmann M; Trautmann ME; Poertl S; Hoermann R; Berger P; Arnold R; Mann K
Eur J Clin Invest; 1994 Feb; 24(2):131-6. PubMed ID: 7515807
[TBL] [Abstract][Full Text] [Related]
6. A new pituitary protein 7B2 is increased in patients with high alpha- or beta-hCG.
Leonhardt U; Eriksson B; Oberg K; Wide L; Ghatei MA; Bloom SR
Acta Endocrinol (Copenh); 1989 Mar; 120(3):289-94. PubMed ID: 2538988
[TBL] [Abstract][Full Text] [Related]
7. Human chorionic gonadotropin and human placental lactogen in extragonadal tumors. An immunoperoxidase study of ten non-germ cell neoplasms.
Heyderman E; Chapman DV; Richardson TC; Calvert I; Rosen SW
Cancer; 1985 Dec; 56(11):2674-82. PubMed ID: 2413978
[TBL] [Abstract][Full Text] [Related]
8. Levels of alpha-subunits of gonadotropins can be increased in Zollinger-Ellison syndrome, both in patients with malignant tumours and with apparently benign disease.
Bardram L; Agner T; Hagen C
Acta Endocrinol (Copenh); 1988 May; 118(1):135-41. PubMed ID: 3389044
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical staining for human chorionic gonadotropin subunits does not predict malignancy in insulinomas.
Graeme-Cook F; Nardi G; Compton CC
Am J Clin Pathol; 1990 Feb; 93(2):273-6. PubMed ID: 1689098
[TBL] [Abstract][Full Text] [Related]
10. Update on pancreatic polypeptide as a specific marker for endocrine tumours of the pancreas and gut.
Oberg K; Grimelius L; Lundqvist G; Lörelius LE
Acta Med Scand; 1981; 210(3):145-52. PubMed ID: 6270987
[TBL] [Abstract][Full Text] [Related]
11. Type I multiple endocrine neoplasias.
Vieto RJ; Hickey RC; Samaan NA
Curr Probl Cancer; 1982 Nov; 7(5):1-25. PubMed ID: 6130893
[No Abstract] [Full Text] [Related]
12. Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors. A specific marker for malignancy.
Kahn CR; Rosen SW; Weintraub BD; Fajans SS; Gorden P
N Engl J Med; 1977 Sep; 297(11):565-9. PubMed ID: 196194
[TBL] [Abstract][Full Text] [Related]
13. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
Ellison EC; O'Dorisio TM; Benson GD
Am J Surg; 1986 Jun; 151(6):668-75. PubMed ID: 2872829
[No Abstract] [Full Text] [Related]
14. Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment.
Blackman MR; Weintraub BD; Rosen SW; Kourides IA; Steinwascher K; Gail MH
J Natl Cancer Inst; 1980 Jul; 65(1):81-93. PubMed ID: 6248674
[No Abstract] [Full Text] [Related]
15. Serum gastrin and human chorionic gonadotropin in the Zollinger-Ellison syndrome.
Stabile BE; Braunstein GD; Passaro E
Arch Surg; 1980 Sep; 115(9):1090-5. PubMed ID: 7416955
[TBL] [Abstract][Full Text] [Related]
16. The expression of subunits of human chorionic gonadotropin (hCG) by nontrophoblastic, nonendocrine, and endocrine tumors.
Heitz PU; von Herbay G; Klöppel G; Komminoth P; Kasper M; Höfler H; Müller KM; Oberholzer M
Am J Clin Pathol; 1987 Oct; 88(4):467-72. PubMed ID: 2444098
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Rehfeld JF
Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
[TBL] [Abstract][Full Text] [Related]
18. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
19. Human chorionic gonadotropin subunit measurement in primary hyperparathyroidism.
Stock JL; Weintraub BD; Rosen SW; Aurbach GD; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 1982 Jan; 54(1):57-63. PubMed ID: 6274898
[TBL] [Abstract][Full Text] [Related]
20. Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
Klöppel G; Girard J; Polak JM; Vaitukaitis JL; Kasper M; Heitz PU
Cancer Detect Prev; 1983; 6(1-2):161-6. PubMed ID: 6309383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
